| Bioactivity | (±)-trans-Lamivudine is separated from the salt of (S)-(+) mandelic acid. (±)-trans-Lamivudine forms cocrystals with (S)-BINOL. (±)-trans-Lamivudine is promising for research of human immunodeficiency virus infection[1]. |
| CAS | 131086-22-1 |
| Formula | C8H11N3O3S |
| Molar Mass | 229.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Roy B N, et al. A novel method for large-scale synthesis of lamivudine through cocrystal formation of racemic lamivudine with (S)-(−)-1, 1’-Bi (2-naphthol)[(S)-(BINOL)][J]. Organic Process Research & Development, 2009, 13(3): 450-455. |
(±)-trans-Lamivudine
CAS: 131086-22-1 F: C8H11N3O3S W: 229.26
(±)-trans-Lamivudine is separated from the salt of (S)-(+) mandelic acid. (±)-trans-Lamivudine forms cocrystals with (
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.